IGF2BP3 and leukemia: Interestingly, there was no consistent decrease in oxidative phosphorylation or relative incorporation from glucose or glutamine into TCA cycle intermediates upon IGF2BP3 loss, suggesting a specific and targeted effect of IGF2BP3 on glycolysis and OCM rather than global depression of overall metabolic rates in these leukemia models.